Procter & Gamble Hygiene and Health Care (BOM:500459) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Procter & Gamble Hygiene and Health Care EBITDA Margin % Related Terms
Procter & Gamble Hygiene and Health Care EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Procter & Gamble Hygiene and Health Care EBITDA Margin % Chart
Procter & Gamble Hygiene and Health Care Annual Data
BOM:500459 vs PG, CL, KVUE: EBITDA Margin % Comparison
For the Household & Personal Products subindustry, Procter & Gamble Hygiene and Health Care's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Procter & Gamble Hygiene and Health Care EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Procter & Gamble Hygiene and Health Care's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Procter & Gamble Hygiene and Health Care's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Procter & Gamble Hygiene and Health Care (BOM:500459) has a EBITDA Margin % of 24.61% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Procter & Gamble Hygiene and Health Care and its competitors. This is near median its historical median of 25.14. Over the past decade, Procter & Gamble Hygiene and Health Care's EBITDA Margin % has ranged from 21.60 to 31.98. According to the industry distribution chart, Procter & Gamble Hygiene and Health Care ranks #147 out of 1951 companies in the Consumer Packaged Goods industry, placing it in the top 7.5%.
Is Procter & Gamble Hygiene and Health Care's EBITDA Margin % too high?
Procter & Gamble Hygiene and Health Care's current EBITDA Margin % of 24.61% is near median its 10-year median of 25.14. Over the past 10 years, this metric has ranged from a low of 21.60 to a high of 31.98. The Consumer Packaged Goods industry median EBITDA Margin % is 8.97. Procter & Gamble Hygiene and Health Care's value of 24.61% is 174.4% above this industry median. Based on the distribution chart, Procter & Gamble Hygiene and Health Care ranks #147 out of 1951 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Procter & Gamble Hygiene and Health Care has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Procter & Gamble Hygiene and Health Care's EBITDA Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Procter & Gamble Hygiene and Health Care ranks #147 out of 1951 companies for EBITDA Margin %. This places Procter & Gamble Hygiene and Health Care in the top 8% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 8.97. Procter & Gamble Hygiene and Health Care's value of 24.61% is 174.4% above this benchmark. Historically, Procter & Gamble Hygiene and Health Care's own EBITDA Margin % has ranged from 21.60 to 31.98 over the past decade. While the company's 10-year median is 25.14 vs. the industry median of 8.97, Procter & Gamble Hygiene and Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.97, based on 1,951 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Procter & Gamble Hygiene and Health Care's current EBITDA Margin % of 24.61% is 174.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Procter & Gamble Hygiene and Health Care and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Procter & Gamble Hygiene and Health Care's current EBITDA Margin % is 24.61%, which is near median its own 10-year median of 25.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procter & Gamble Hygiene and Health Care stock overvalued right now?
Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care (BOM:500459) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹15,961.56, compared to a current price of ₹9,025.10 — trading 43.5% below its estimated fair value. The current EBITDA Margin % is 24.61%, which is near median its 10-year median of 25.14 and 174.4% above the Consumer Packaged Goods industry median of 8.97. Procter & Gamble Hygiene and Health Care's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Procter & Gamble Hygiene and Health Care (BOM:500459), the current EBITDA Margin % is 24.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Procter & Gamble Hygiene and Health Care (BOM:500459) Overvalued in 2026?
Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care stock appears to be undervalued.
The current stock price of ₹9,025.10 is trading 43.5% below its estimated GF Value™ of ₹15,961.56.
GuruFocus considers Procter & Gamble Hygiene and Health Care to be Significantly Undervalued.
Key valuation signals for BOM:500459:
EBITDA Margin %: 24.61% (near median its 10-year median of 25.14)
GF Value™: ₹15,961.56 vs. price of ₹9,025.10 (43.5% below fair value)
Industry Position: 174.4% above the Consumer Packaged Goods median (#147 of 1951)
No single metric tells the full story. See the BOM:500459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Procter & Gamble Hygiene and Health Care Business Description
Procter & Gamble Hygiene and Health Care Ltd is an Indian company engaged in the manufacturing and selling of feminine hygiene care and healthcare products. The portfolio includes brands like Ambi Pur, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide Ariel, Duracell, Gillette, Vicks, and Wella. The business is divided into a feminine hygiene business and a healthcare business. The feminine hygiene business offers sanitary napkins and feminine sanitary hygiene products; its popular brand is Whisper. The healthcare business offers creams, cough drops, and other health products. The company distributes its products through various channels: from retail locations such as mass merchandizers and grocery stores, to drug stores and department stores.
79GF Score
Get the complete analysis for BOM:500459
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500459 has been successfully added to your 
